Clinical Trial Update: Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating durvalumab and tremelimumab in combination with propranolol and chemotherapy for advanced hepatopancreatobiliary tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Hepatocellular Carcinoma
• Pancreatic Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Propranolol (propranolol)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Pancreatic Cancer, Hepatocellular Cancer | Phase 2 | Status: RECRUITING